A
Adriana Ceci
Researcher at University of Bari
Publications - 87
Citations - 1957
Adriana Ceci is an academic researcher from University of Bari. The author has contributed to research in topics: Population & Deferiprone. The author has an hindex of 24, co-authored 80 publications receiving 1748 citations.
Papers
More filters
Journal ArticleDOI
The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients
Adriana Ceci,Paola Baiardi,Mariagrazia Felisi,Maria Domenica Cappellini,Vittorio Carnelli,Vincenzo De Sanctis,Renzo Galanello,Aurelio Maggio,Giuseppe Masera,Antonio Piga,Francesco Schettini,Ippazio Stefàno,Fernando Tricta +12 more
TL;DR: These data show that the drug was effective in reducing serum ferritin levels and the incidence of adverse events was not greater than the frequency reported in clinical trials.
Journal ArticleDOI
Drug use in children: cohort study in three European countries
Miriam C. J. M. Sturkenboom,Katia M.C. Verhamme,Alfredo Nicolosi,Macey L. Murray,Antje Neubert,Daan Caudri,Gino Picelli,Elif F. Sen,Carlo Giaquinto,Luigi Cantarutti,Paola Baiardi,Maria Grazia Felisi,Adriana Ceci,Ian C. K. Wong +13 more
TL;DR: An overview of outpatient paediatric prescription patterns in a large European population could provide information to prioritise paediatric therapeutic research needs.
Journal ArticleDOI
Defining off-label and unlicensed use of medicines for children: results of a Delphi survey.
Antje Neubert,Ian C. K. Wong,Alessandro Bonifazi,Mariana Catapano,Mariagrazia Felisi,Paola Baiardi,Carlo Giaquinto,Catherijne A. J. Knibbe,Miriam C. J. M. Sturkenboom,Maisoon Abdullah Ghaleb,Adriana Ceci +10 more
TL;DR: The Delphi panel agreed that the definitions for unlicensed and off-label drug use in children should be circulated within the scientific community and recommended to be adopted by relevant regulatory authorities.
Journal ArticleDOI
Langerhans cell histiocytosis in childhood: results from the Italian Cooperative AIEOP-CNR-H.X '83 study.
Adriana Ceci,Marino de Terlizzi,Roberto Colella,G. Loiacono,Donato Balducci,Giammarco Surico,Manuel A. Castello,Anna Maria Testi,Bruno De Bernardi,Paolo Indolfi,Pierantonio Macchia,Enrico Madon,Antonia Mancini,Domenico Rosati +13 more
TL;DR: Monochemotherapy is probably adequate in GP patients, while more effective treatments are needed for PP patients.
Journal ArticleDOI
Medicines for children licensed by the European Medicines Agency (EMEA): the balance after 10 years
Adriana Ceci,Mariagrazia Felisi,Paola Baiardi,Fedele Bonifazi,Mariana Catapano,Carlo Giaquinto,Alfredo Nicolosi,Miriam C. J. M. Sturkenboom,Antje Neubert,Ian C. K. Wong +9 more
TL;DR: The total number of paediatric medicines approved by EMEA is stable over the 10-year period, while an increase in drugs to treat serious or orphan diseases has been observed.